BD company Wikipedia
1954 Production of the first disposable syringes to be used in the Salk Polio vaccine trial takes place. 1988 BD launched the first safety engineered syringe. 1991 BD opens a central distribution center in Temsee, Belgium to ship medical products across Europe, the middle east, and Africa. 1995 A joint venture was established in China to produce medical products for China. 1995 A joint venture was established in China to produce medical products for China.\r\n 2007 BD participates in PEPFAR, the U.S. government’s global effort to combat HIV and the largest global health program devoted to a single disease.
1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles. 1972 BD launched the first florescence-activated cell sorter. 1981 A new plant is built in Plymouth, England to manufacture BD Vacutainer® system products and serve a growing European market. 1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan.
BD FACSDiscover™ S8 Cell Sorter
- “Jack” Howe joins BD and becomes integral to developing sterility control procedures and refining the process for manufacturing disposable syringes and needles.
- 1972 BD launched the first florescence-activated cell sorter.
- 2020 BD launched the first sample preparation and flow cytometry system to enable clinical laboratories to fully automate the sample-to-answer process.
- With a focus on quality, reliability, and continuous innovation, the Medical Essentials segment is driving better outcomes across the care continuum.
By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.
Sign Up for Job Alerts
A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory. Explore a variety of tools for your multicolor flow cytometry, from panel design to selection tools—an array of aids to support your research. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.
In April 2016, the Occupational Safety and Health Administration fined BD US$112,700 for safety violations. Pfitzer et al. (2013) identify BD’s development of a needleless injection system as an example of leading businesses’ role in creating shared value. The company’s line of plastic conical screwtop test tubes, known as ‘Falcon tubes’, is popular and the term is sometimes used as a generic https://khelaghor-bangladesh.com/bd/ term for such tubes.
1999 The world’s shortest, thinnest insulin pen needle is introduced. 2007 BD AutoShield™ needle is launched. 2015 BD became the first to integrate IV pumps with electronic health records. 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.
Based in Mexico City, to produce syringes, needles and clinical thermometers for the Mexican market. 1995 BD formed a subsidiary in India to manufacture insulin syringes and to market other medical and diagnostic products to the region. We welcome people with imagination and drive – people who want to grow, make a difference and help reinvent the future of healthcare. As one of the largest global medical technology companies, we develop solutions that improve diagnostics, enhance care and transform lives around the world.